A New Prognostic Stratification-based Safety and Efficacy Study of Ruxolitinib in Myelofibrosis
Clinical trial NCT05447260 · UNKNOWN
Trial details
- NCT number
- NCT05447260
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-10
- Primary completion
- 2022-12-10
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.